Ashish V. Joshi, PhD

home / authors / ashish-v-joshi-phd

Articles

October 23rd 2013

Inefficiencies in Osteoarthritis and Chronic Low Back Pain Management

Margaret K. Pasquale, PhD Robert Dufour, PhD Ashish V. Joshi, PhD Andrew T. Reiners, MD David Schaaf, MD Jack Mardekian, PhD George A. Andrews, MD, MBA, CPE Nick C. Patel, PharmD, PhD, BCPP James Harnett, PharmD, MS

This study identified inefficiencies in drug and medical service utilization related to pain management among Medicare members with osteoarthritis and chronic low back pain.

July 14th 2011

Impact of Celecoxib Restrictions in Medicare Beneficiaries With Arthritis

Anthony M. Louder, PhD, RPh Ashish V. Joshi, PhD Amy T. Ball, PharmD Joseph C. Cappelleri, PhD Michael C. Deminski, MS, RPh Robert J. Sanchez, PhD

A formulary restriction policy in a Medicare population was associated with lower celecoxib utilization; however, higher gastrointestinal- and arthritis-related medical costs were observed.

June 10th 2010

Healthcare Utilization and Cost Effects of Prior Authorization for Pregabalin in Commercial Health Plans

Jay M. Margolis, PharmD Zhun Cao, PhD Eberechukwu Onukwugha, PhD Robert J. Sanchez, MS Jose Alvir, DrPH Ashish V. Joshi, PhD C. Daniel Mullins, PhD

Prior authorization for pregabalin in commercial insurance plans accomplished the objective of lower pregabalin utilization; however, there was no significant decrease in disease-related healthcare costs.

June 1st 2010

Impact of a Prior Authorization for Pregabalin on Health Plan Drug Expenditures

Gary Bazalo, MS, MBA Richard C. Weiss, MS Ashish V. Joshi, PhD